Skip to main content
. 2022 Mar 8;10(3):626. doi: 10.3390/biomedicines10030626

Table 1.

Comparison of clinicopathological factors and SMOX expression in patients with CRC.

Clinicopathological Factors SMOX Expression Total
(N = 350)
p Value
Low (N = 182) High (N = 168)
Age, years, mean (SD) 67 (12.8) 68 (12.6) 67 (12.7) 0.059
Gender, N (%) 0.04
M 85 (57.8) 62 (42.2) 147
F 97 (47.8) 106 (52.2) 203
pT, N (%) 0.197
pT1 and pT2 15 (62.5) 9 (37.5) 24
pT3 and pT4 167 (51.2) 159 (48.8) 326
pN, N (%) 0.296
pN0 and pN1 112 (50.7) 109 (49.3) 221
pN2 and pN3 70 (54.3) 59 (45.7) 129
Metastasis, N (%) 0.103
Negative 173 (53.1) 153 (46.9) 326
Positive 9 (37.5) 15 (62.5) 24
Vascular invasion, N (%) 0.115
Negative 157 (53.6) 136 (46.4) 293
Positive 25 (43.9) 32 (56.1) 57
Lymphatic invasion, N (%) 0.498
Negative 130 (52.2) 119 (47.8) 249
Positive 52 (51.5) 49 (48.5) 101
Stage, N (%) 0.195
Ⅰ and Ⅱ 99 (49.7) 100 (50.3) 199
Ⅲ and Ⅳ 83 (55.0) 68 (45.0) 151